Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Optimal myocardial preconditioning in humans.

G Cohen1, T Shirai, R D Weisel

  • 1Division of Cardiovascular Surgery, Toronto Hospital, Ontario, Canada.

Annals of the New York Academy of Sciences
|July 23, 1999
PubMed
Summary

Preconditioning protects human heart cells during ischemia and reperfusion injury, primarily through adenosine signaling. Adenosine administration during cardiac surgery benefits myocardial metabolism and preserves energy phosphates.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Development of a respiratory virus panel test for detection of twenty human respiratory viruses by use of multiplex PCR and a fluid microbead-based assay.

Journal of clinical microbiology·2007
Same author

Angiogenesis: protein, gene, or cell therapy?

The heart surgery forum·2002
Same author

Optimal time for cardiomyocyte transplantation to maximize myocardial function after left ventricular injury.

The Annals of thoracic surgery·2002
Same author

Angiogenesis by endothelial cell transplantation.

The Journal of thoracic and cardiovascular surgery·2001
Same author

Enhanced myocardial angiogenesis by gene transfer with transplanted cells.

Circulation·2001
Same author

Lactate release during reperfusion predicts low cardiac output syndrome after coronary bypass surgery.

The Annals of thoracic surgery·2001

Area of Science:

  • Cardiology
  • Cellular Biology
  • Biochemistry

Background:

  • Ischemia and reperfusion (I and R) injury is a significant clinical problem.
  • Preconditioning (PC) strategies aim to protect cardiac myocytes (CM) from I and R damage.
  • The role of adenosine in endogenous and exogenous PC requires further elucidation.

Purpose of the Study:

  • To investigate the protective mechanisms of preconditioning in human ventricular myocytes.
  • To determine the role of adenosine in mediating preconditioning effects.
  • To assess the clinical efficacy of adenosine in myocardial protection during coronary artery bypass grafting (CABG).

Main Methods:

  • Development of an in vitro model of I and R in human ventricular myocytes.
  • Evaluation of cellular injury and metabolic parameters under various preconditioning interventions (anoxia, hypoxia, adenosine, SPT).

Related Experiment Videos

  • Clinical assessment in patients undergoing CABG, comparing high-dose, low-dose, and no adenosine, with analysis of adenosine levels and high-energy phosphates.

    • Main Results:

    • Cellular models demonstrated that preconditioning protects human CM via an adenosine-mediated pathway.
    • Adenosine mimicked preconditioning effects without reducing ATP levels.
    • In CABG patients, adenosine administration stimulated myocardial metabolism and prevented high-energy phosphate degradation.

    Conclusions:

    • Adenosine is a key mediator of preconditioning-induced protection in human cardiac myocytes.
    • Adenosine administration shows potential for myocardial protection during cardiac surgery.
    • Further prospective randomized trials are warranted to confirm adenosine's efficacy in high-risk patients.